6206-17-3 Usage
Chemical Class
Nucleoside analog
Structural Similarity
To the building blocks of DNA and RNA
Field of Application
Medicinal chemistry and drug development
Potential Properties
Antiviral and anticancer
Mechanism of Action
Inhibition of replication of certain viruses
Chemical Structure
Includes a pyrimidine base, a sugar molecule, and an azide functional group
Biological Activity
Contributes to its potential therapeutic applications
Research Potential
Could lead to the development of new and effective treatments for a variety of diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 6206-17-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,0 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6206-17:
(6*6)+(5*2)+(4*0)+(3*6)+(2*1)+(1*7)=73
73 % 10 = 3
So 6206-17-3 is a valid CAS Registry Number.
6206-17-3Relevant articles and documents
1-(2,3-anhydro-β-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus
Webb,Mitsuya,Broder
, p. 1475 - 1479 (2007/10/02)
We report here that 1-(2,3-anhydro-β-D-lyxofuranosyl)cytosine has activity against the human immunodeficiency virus in vitro. A number of 2',3'-anhydro-β-D-lyxofuranosyl nucleoside derivatives were prepared, but none had the activity of the title compound. New efficient procedures were developed for the synthesis of 3'-deoxy-3'-alkyl- and 3'-deoxy-β-D-arabinosylpyrimidine derivatives.
